Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Analog Devices (ADI) is an Incredible Growth Stock: 3 Reasons Why
Analog Devices (ADI) is an Incredible Growth Stock: 3 Reasons Why

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

UBER Stock Plunges 23.4% in 6 Months:Time to Hold or Fold?
UBER Stock Plunges 23.4% in 6 Months:Time to Hold or Fold?

Shares of Uber Technologies UBER) have declined 23.4% over the past six months against the Zacks  Internet-Services industry’s growth of 20.7%. However, it outperformed fellow industry players, Lyft

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

Kymera Therapeutics KYMR announced that the FDA has granted a Fast Track designation to its lead candidate, KT-621, for the treatment of moderate-to-severe eosinophilic asthma. KYMR shares rose 4%

NU Appears Expensive to Its Industry: Is the Premium Warranted?
NU Appears Expensive to Its Industry: Is the Premium Warranted?

Nu Holdings Ltd. NU is currently trading at a 16.1X forward 12-month price-to-earnings, substantially higher than the industry’s 10.91X. While the stock appears expensive, the forward-looking

Momentum ETF (SPMO) Hits New 52-Week High
Momentum ETF (SPMO) Hits New 52-Week High

Invesco S&P 500 Momentum ETF SPMO is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 46.84% from its 52-week low price of $84.86 per share.

Surging Earnings Estimates Signal Upside for Peloton (PTON) Stock
Surging Earnings Estimates Signal Upside for Peloton (PTON) Stock

Peloton (PTON) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its

Earnings Estimates Rising for Murphy Oil (MUR): Will It Gain?
Earnings Estimates Rising for Murphy Oil (MUR): Will It Gain?

Murphy Oil (MUR) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with

MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer
MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer

Merck MRK and its Japanese partner Daiichi Sankyo announced that the FDA has accepted the biologics license application (BLA) seeking approval for ifinatamab deruxtecan (I-DXd), a B7-H3-directed DXd

HSBC Launches TDS in U.S., Boosts Digital Payments & Global Liquidity
HSBC Launches TDS in U.S., Boosts Digital Payments & Global Liquidity

HSBC Holdings plc HSBC has introduced its Tokenized Deposit Service (TDS) in the United States to enable faster and smoother money transfers using blockchain technology. The move represents the

Terreno Announces Completion of Property Development in Hialeah
Terreno Announces Completion of Property Development in Hialeah

Terreno Realty Corporation TRNO announced that it recently completed the development and stabilization of Countyline Corporate Park Phase IV Building 34 in Hialeah, FL, for a total investment of

Why Corpay (CPAY) Could Beat Earnings Estimates Again
Why Corpay (CPAY) Could Beat Earnings Estimates Again

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Corpay (CPAY)

Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?
Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Royalty Pharma

Why Ally Financial (ALLY) Could Beat Earnings Estimates Again
Why Ally Financial (ALLY) Could Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Ally Financial (ALLY), which belongs to

Why Honeywell International (HON) Could Beat Earnings Estimates Again
Why Honeywell International (HON) Could Beat Earnings Estimates Again

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Honeywell

Shopify Trades 37% Below 52-Week High: Is the Stock Still a Buy?
Shopify Trades 37% Below 52-Week High: Is the Stock Still a Buy?

Shopify SHOP shares closed at $114.97 on Monday, which was 36.9% lower than the 52-week high of $182.19 it hit on Oct. 29. SHOP shares have dropped 28.6% year to date, underperforming the broader

Regeneron Boosts Cancer Pipeline Through Telix Collaboration
Regeneron Boosts Cancer Pipeline Through Telix Collaboration

Regeneron Pharmaceuticals REGN announced that it has entered into a strategic collaboration with Telix Pharmaceuticals Limited TLX to co-develop and co-commercialize next-generation

MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes
MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes

Medline Inc. (MDLN recently received a warning letter from the FDA, citing multiple violations related to manufacturing and quality system processes at its New York facility. The regulatory action

How Will Visa's Neat Partnership Help Boost Engagement and Growth?
How Will Visa's Neat Partnership Help Boost Engagement and Growth?

Visa Inc. V recently announced a new partnership with Neat to enhance the insurance and medical assistance services embedded within its cards. The collaboration underscores a broader move toward

Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results
Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results

Johnson & Johnson’s (NYSE: JNJ) price action entered consolidation in early March. While it may continue moving sideways or even pull back further, those moves are unlikely, given a convergence of

UiPath Stock Slides 39% in Six Months: a Buying Opportunity or a Hold?
UiPath Stock Slides 39% in Six Months: a Buying Opportunity or a Hold?

UiPath Inc. PATH has faced significant selling pressure in recent months, with its stock declining 39% over the past six months and 10% over the last three months. This sharp pullback reflects a